Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. - Wikidata - awgldk - TriplyDB

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

http://www.wikidata.org/entity/Q50176817

about

Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.'Miracle stents'--a future without restenosis Dual antiplatelet therapy: optimal timing, management, and duration Is There Any Significant Difference in Stent Thrombosis Between Sirolimus and Paclitaxel Eluting Stents?: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014 Adipose tissue-derived stem cells as a therapeutic tool for cardiovascular disease The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence Luminal flow amplifies stent-based drug deposition in arterial bifurcations Rapamycin regulates the expression and activity of Krüppel-like transcription factor 2 in human umbilical vein endothelial cells Two-year results of an open-label randomized comparison of everolimus-eluting stents and sirolimus-eluting stents Efficacy and safety of biodegradable polymer biolimus-eluting stents versus durable polymer drug-eluting stents: a meta-analysis RETRACTED: Drug-eluting stents for acute coronary syndrome: a meta-analysis of randomized controlled trials Clinical outcomes in low risk coronary artery disease patients treated with different limus-based drug-eluting stents--a nationwide retrospective cohort study using insurance claims database Evaluation of long-term clinical and health service outcomes following coronary artery revascularisation in Western Australia (WACARP): a population-based cohort study protocol Advances in stent technologies and their effect on clinical efficacy and safety Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials.Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials.Applications of optical coherence tomography in cardiovascular medicine, Part 2 Biomaterials in cochlear implants.Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.Experience with biodegradable polymer coated sirolimus-eluting coronary stent system in "real-life" percutaneous coronary intervention: 24-month data from the manipal-s registry Patient-Centered Tablet Application for Improving Medication Adherence after a Drug-Eluting Stent.Comparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry.Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program.Nanomedicine for the reduction of the thrombogenicity of stent coatings.Vascular response profiles following a nano polymer-free sirolimus-eluting stent implantation assessed by optical coherence tomography in a porcine model The effect of cilostazol on stent thrombosis after drug-eluting stent implantation Hemodynamically driven stent strut design Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: design and statistical methods of the PERSEUS clinical program Preclinical study of a biodegradable polymer-based stent with abluminal sirolimus release.Rapamycin regulates endothelial cell migration through regulation of the cyclin-dependent kinase inhibitor p27Kip1.Long-term outcomes of drug-eluting versus bare-metal stent for ST-elevation myocardial infarction A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study.A rapamycin-releasing perivascular polymeric sheath produces highly effective inhibition of intimal hyperplasia.Predicting target vessel revascularization in older patients undergoing percutaneous coronary intervention in the drug-eluting stent era Endothelialization and in-stent restenosis on the surface of glycoprotein IIIa monoclonal antibody eluting stent.Late outcomes following percutaneous coronary interventions: results from a large, observational registry.Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomize

P2860

Q24605881-19178544-337F-4001-BB5E-00D5518FF926 Q24645049-1729123F-7100-48BD-AE74-6537838C0737 Q26741055-BF1FCE37-3150-45C7-AD78-31D9225BC811 Q26769033-78375635-6F0B-4F51-9FD0-A6DE1E4C76C2 Q26785321-CA5D9C84-92E7-4EE1-811A-6B005FCDE190 Q26795749-E81401B2-487F-46E1-A6BC-6A56FC260A88 Q28067509-A5664427-8557-443D-9733-C7905C60364C Q28472148-77142103-CD03-4BDA-B648-704DA040ACD6 Q28482627-FDD311C0-B8BD-4AA3-B156-7F6379EB8322 Q28533603-2649251A-EAE8-4773-B9FD-9506027C75AD Q28534994-318CAF3D-40E7-42D9-AB0B-7EDC62C46B8C Q28536811-3C9619F8-B220-4A11-A78D-BDF19414AF22 Q28545812-6A5D4F0D-0E86-458A-9AE2-EAA934064C62 Q28654972-025A0996-70B7-4476-990A-2E7245379788 Q28972437-415498BC-FA50-4437-95EF-C0D773F45101 Q30241829-B06CBECC-543C-4780-883E-495B8057406E Q30251867-A5DAEC96-2466-42CB-9480-046F10C35B3A Q30417079-F465070D-53B0-41AA-A8CE-BD984977E66B Q30472996-85311415-FD84-4283-BC7C-A5C8BE7F36A8 Q30475719-E6CBEFCD-7931-45CA-98E9-3DDC4ABF8801 Q30687588-8B8F5AF7-E8F8-4BF1-B727-B94C6026F113 Q30831522-741EBD04-8756-4ADE-BA7A-D9FCFF72231D Q31043691-A415D9E9-5B1F-4E31-B289-201805CCA8A5 Q33437306-D01C1724-0AC5-4264-854D-6911D3EA89DD Q33571243-1EE2C4E2-390B-4638-9335-74B593734931 Q33576893-87A4FD90-36D1-414E-BC92-5421215EA3AD Q33598021-51557A8A-6C68-43F4-B4C1-50C28F0864EB Q33616230-C575DE91-996E-423A-966F-8550C51785D0 Q33644087-5FEF3B29-88FB-41D4-985D-4BE898F3BD7D Q33649631-E886F491-D7B8-4C04-92DB-1B5AF77BB707 Q33677854-6ECE494B-B7DA-42CB-8074-37EB7085F72E Q33733393-BA6F14E2-6E7D-4AE1-96F8-C94DCC8348C9 Q33782496-9511E9AA-0F07-498B-AD8E-6A2A0662A93C Q33835973-FE3338F7-10DA-41C8-839C-A401F84DD303 Q33854333-A5A20493-5022-4376-8C90-202A587054B3 Q34145417-ABA881E4-C0C6-4994-95B7-40314E7DDF8D Q34149049-A45210B4-F439-46DA-9038-1B6C097868EB Q34177967-F3F9EC89-3A63-4CFE-AF46-5B29143C7555 Q34179087-493C5834-5CA1-4B76-9DD0-1ABB061903D4 Q34207990-A7DAD1B8-358E-43B4-A47A-EFF4ED657B40

P2860

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

http://www.wikidata.org/entity/Q50176817

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

@en

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

@nl

type

label

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

@en

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

@nl

prefLabel

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

@en

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

@nl

P1433

Q50176817-39F26435-C57B-4DF1-8710-1FCEFB393985

P1476

Q50176817-F0D0B2D1-EDC9-41C2-89BD-B7E770E49D3E

P2093

Q50176817-0A44DE80-549B-40FD-86C3-A8C2C95A1A4A

Q50176817-0B702D64-EBF8-49BA-97E1-61A4F24AC9A8

Q50176817-224CA6EB-8A5D-4747-87DF-334C980C6897

Q50176817-3C53B032-37D5-4DFC-9EC7-F71FEB308E80

Q50176817-45E2EB67-15B4-4607-92A7-49B9EBA82C1A

Q50176817-52B85842-2A81-48DB-A2B7-0CE926F3A91E

Q50176817-5D9E85C7-03B5-40BE-8117-60EBD562A021

Q50176817-8CA0375C-49B8-476A-A637-8A48D62495F9

Q50176817-B0B8F6A3-F578-4CEA-9DB7-95C3A764BB51

Q50176817-E73FC99E-BE28-4750-A4D9-C70A3EC27E90

P304

Q50176817-5A95A2AC-F632-4161-B83C-F26D71F4157F

P31

Q50176817-2A5E96BE-FA7C-4E0A-A7A2-3BF09C316F19

Q50176817-a8951c6d-6690-43b3-9532-db05942ac031

P356

Q50176817-1D8F206F-8D00-4132-B380-3237943110FA

P407

Q50176817-42ACA0C7-F2B9-49A6-841C-A508265BE1D9

P433

Q50176817-7BA03112-6443-45AB-ADB8-D30E6531297B

P478

Q50176817-7713243C-4C3A-40F1-80AE-8A81B0A38EB3

P50

Q50176817-12213D60-BC0A-4EAC-B8F6-0F58A02CA4E6

Q50176817-7907E741-BDCC-4661-BBC4-FC3B17DB990F

Q50176817-7E3A64E5-944A-4F2A-B9B3-519DBAAE315E

Q50176817-A532B351-6AA6-480A-93E6-9BB5F000E326

Q50176817-EFE749EB-F4BC-4D92-832B-7159651F98D1

P577

Q50176817-6B4006F0-C975-43A5-8E9D-58CA5257B523

P698

Q50176817-26952CAA-6BE4-4447-ADE5-F41FFF40FF12

P356

P1433

The New England Journal of Medicine

P1476

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

@en

P2093

Antonio Colombo

http://www.w3.org/2001/XMLSchema#string

Donald E Cutlip

http://www.w3.org/2001/XMLSchema#string

Eberhard Grube

http://www.w3.org/2001/XMLSchema#string

Gregg W Stone

http://www.w3.org/2001/XMLSchema#string

Jeffrey W Moses

http://www.w3.org/2001/XMLSchema#string

Joachim Schofer

http://www.w3.org/2001/XMLSchema#string

Keith D Dawkins

http://www.w3.org/2001/XMLSchema#string

Martin B Leon

http://www.w3.org/2001/XMLSchema#string

Martin Fahy

http://www.w3.org/2001/XMLSchema#string

Stuart J Pocock

http://www.w3.org/2001/XMLSchema#string

P304

998-1008

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA067193

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

356

http://www.w3.org/2001/XMLSchema#string

P50

Erick Schampaert

Stephen G. Ellis

Marie-Claude Morice

P577

2007-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17296824

http://www.w3.org/2001/XMLSchema#string